Predicting recognition between T cell receptors and epitopes with TCRGP.

by Emmi Jokinen, Jani Huuhtanen, Satu Mustjoki, Markus Heinonen, Harri Lähdesmäki
Published 2021-03-01

Enlarged memory T-cell pool and enhanced Th1-type responses in chronic myeloid leukemia patients who have successfully discontinued IFN-α monotherapy.

by Mette Ilander, Anna Kreutzman, Peter Rohon, Teresa Melo, Edgar Faber, Kimmo Porkka, Jukka Vakkila, Satu Mustjoki
Published 2014-01-01

The use of multiplex platforms for absolute and relative protein quantification of clinical material

by Lisa Christiansson, Satu Mustjoki, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S.I. Loskog, Sara M. Mangsbo
Published 2014-06-01

Prognostic Impact of Tumor-Associated Macrophages on Survival Is Checkpoint Dependent in Classical Hodgkin Lymphoma

by Kristiina Karihtala, Suvi-Katri Leivonen, Oscar Brück, Marja-Liisa Karjalainen-Lindsberg, Satu Mustjoki, Teijo Pellinen, Sirpa Leppä
Published 2020-04-01

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia.

by Lisa Christiansson, Stina Söderlund, Emma Svensson, Satu Mustjoki, Mats Bengtsson, Bengt Simonsson, Ulla Olsson-Strömberg, Angelica S I Loskog
Published 2013-01-01

Author Correction: Clonal hematopoiesis in patients with rheumatoid arthritis

by Paula Savola, Sofie Lundgren, Mikko A. I. Keränen, Henrikki Almusa, Pekka Ellonen, Marjatta Leirisalo-Repo, Tiina Kelkka, Satu Mustjoki
Published 2021-02-01

Early BCR-ABL1 Transcript Decline after 1 Month of Tyrosine Kinase Inhibitor Therapy as an Indicator for Treatment Response in Chronic Myeloid Leukemia.

by Mohamed El Missiry, Henrik Hjorth-Hansen, Johan Richter, Ulla Olson-Strömberg, Leif Stenke, Kimmo Porkka, Anna Kreutzman, Satu Mustjoki
Published 2017-01-01

Immune cell phenotype and functional defects in Netherton syndrome

by Elina Eränkö, Mette Ilander, Mirja Tuomiranta, Antti Mäkitie, Tea Lassila, Anna Kreutzman, Paula Klemetti, Satu Mustjoki, Katariina Hannula-Jouppi, Annamari Ranki
Published 2018-11-01

Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

by Tiina Kelkka, Tiina Kelkka, Tiina Kelkka, Tiina Kelkka, Paula Savola, Paula Savola, Paula Savola, Paula Savola, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Jani Huuhtanen, Jani Huuhtanen, Jani Huuhtanen, Jani Huuhtanen, Tapio Lönnberg, Matti Kankainen, Matti Kankainen, Matti Kankainen, Kirsi Paalanen, Mikko Tyster, Mikko Tyster, Mikko Tyster, Mikko Tyster, Maija Lepistö, Pekka Ellonen, Johannes Smolander, Samuli Eldfors, Bhagwan Yadav, Bhagwan Yadav, Bhagwan Yadav, Bhagwan Yadav, Sofia Khan, Riitta Koivuniemi, Christopher Sjöwall, Laura L. Elo, Laura L. Elo, Harri Lähdesmäki, Yuka Maeda, Hiroyoshi Nishikawa, Marjatta Leirisalo-Repo, Tuulikki Sokka-Isler, Tuulikki Sokka-Isler, Satu Mustjoki, Satu Mustjoki, Satu Mustjoki, Satu Mustjoki
Published 2020-11-01

Corrigendum: Adult-Onset Anti-Citrullinated Peptide Antibody-Negative Destructive Rheumatoid Arthritis Is Characterized by a Disease-Specific CD8+ T Lymphocyte Signature

by Tiina Kelkka, Tiina Kelkka, Tiina Kelkka, Tiina Kelkka, Paula Savola, Paula Savola, Paula Savola, Paula Savola, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Dipabarna Bhattacharya, Jani Huuhtanen, Jani Huuhtanen, Jani Huuhtanen, Jani Huuhtanen, Tapio Lönnberg, Matti Kankainen, Matti Kankainen, Matti Kankainen, Kirsi Paalanen, Mikko Tyster, Mikko Tyster, Mikko Tyster, Mikko Tyster, Maija Lepistö, Pekka Ellonen, Johannes Smolander, Samuli Eldfors, Bhagwan Yadav, Bhagwan Yadav, Bhagwan Yadav, Bhagwan Yadav, Sofia Khan, Riitta Koivuniemi, Christopher Sjöwall, Laura L. Elo, Laura L. Elo, Harri Lähdesmäki, Yuka Maeda, Hiroyoshi Nishikawa, Marjatta Leirisalo-Repo, Tuulikki Sokka-Isler, Tuulikki Sokka-Isler, Satu Mustjoki, Satu Mustjoki, Satu Mustjoki, Satu Mustjoki
Published 2021-05-01

<i>STAT3</i> Mutation Is Associated with STAT3 Activation in CD30⁺ ALK⁻ ALCL

by Emma I. Andersson, Oscar Brück, Till Braun, Susanna Mannisto, Leena Saikko, Sonja Lagström, Pekka Ellonen, Sirpa Leppä, Marco Herling, Panu E. Kovanen, Satu Mustjoki
Published 2020-03-01

Chronic myeloid leukemia patients in prolonged remission following interferon-α monotherapy have distinct cytokine and oligoclonal lymphocyte profile.

by Anna Kreutzman, Peter Rohon, Edgar Faber, Karel Indrak, Vesa Juvonen, Veli Kairisto, Jaroslava Voglová, Marjatta Sinisalo, Emília Flochová, Jukka Vakkila, Petteri Arstila, Kimmo Porkka, Satu Mustjoki
Published 2011-01-01

Novel TMEM173 Mutation and the Role of Disease Modifying Alleles

by Salla Keskitalo, Emma Haapaniemi, Emma Haapaniemi, Elisabet Einarsdottir, Elisabet Einarsdottir, Kristiina Rajamäki, Hannele Heikkilä, Mette Ilander, Mette Ilander, Minna Pöyhönen, Minna Pöyhönen, Ekaterina Morgunova, Kati Hokynar, Sonja Lagström, Sirpa Kivirikko, Sirpa Kivirikko, Satu Mustjoki, Satu Mustjoki, Kari Eklund, Kari Eklund, Janna Saarela, Juha Kere, Juha Kere, Juha Kere, Mikko R. J. Seppänen, Mikko R. J. Seppänen, Annamari Ranki, Katariina Hannula-Jouppi, Katariina Hannula-Jouppi, Markku Varjosalo
Published 2019-12-01

Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis

by P. Savola, T. Kelkka, H. L. Rajala, A. Kuuliala, K. Kuuliala, S. Eldfors, P. Ellonen, S. Lagström, M. Lepistö, T. Hannunen, E. I. Andersson, R. K. Khajuria, T. Jaatinen, R. Koivuniemi, H. Repo, J. Saarela, K. Porkka, M. Leirisalo-Repo, S. Mustjoki
Published 2017-06-01

JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL

by Linus Wahnschaffe, Till Braun, Sanna Timonen, Anil K. Giri, Alexandra Schrader, Prerana Wagle, Henrikki Almusa, Patricia Johansson, Dorine Bellanger, Cristina López, Claudia Haferlach, Marc-Henri Stern, Jan Dürig, Reiner Siebert, Satu Mustjoki, Tero Aittokallio, Marco Herling
Published 2019-11-01

Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line

by Anna Kreutzman, Bhagwan Yadav, Tim H. Brummendorf, Bjorn Tore Gjertsen, Moon Hee Lee, Jeroen Janssen, Tiina Kasanen, Perttu Koskenvesa, Kourosh Lotfi, Berit Markevärn, Ulla Olsson-Strömberg, Jesper Stentoft, Leif Stenke, Stina Söderlund, Lene Udby, Johan Richter, Henrik Hjorth-Hansen, Satu Mustjoki
Published 2019-09-01

Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vi...

by Sara Feola, Manlio Fusciello, Beatriz Martins, Erkko Ylösmäki, Vincenzo Cerullo, Firas Hamdan, Jacopo Chiaro, Yvonne Giannoula, Maeve Long, Michaela Feodoroff, Gabriella Antignani, Salvatore Russo, Otto Kari, Moon Lee, Petrus Järvinen, Harry Nisen, Anna Kreutzman, Jeanette Leusen, Satu Mustjoki, Thomas G McWilliams, Mikaela Grönholm
Published 2021-08-01